A case report about a Sclerodermiform syndrome induced by anthracyclines

Kholoud Rharib *, Layla Bendaoud, Maryem Aboudourib, Ouafa Hocar and Said Amal

Dermatology venerology department, CHU Med VI Biosciences and health laboratories, Faculty of Medicine and Pharmacy, Marrakech, Morocco.
 
Case Study
World Journal of Advanced Research and Reviews, 2024, 24(02), 940–942
Article DOI: 10.30574/wjarr.2024.24.2.3395
 

 

Publication history: 
Received on 28 September 2024; revised on 05 November 2024; accepted on 07 November 2024
 
Abstract: 
We report the case of a 43-year-old woman with non-metastatic breast adenocarcinoma, treated with 4 courses of antracyclines and 4 courses of taxanes. After the 3rd course of antracyclines, admitted via peripheral vein at the level of the crease of the right elbow, she presented with painful dermo-hypodermitis over the right antero-lateral aspect of the right elbow, non-febrile, clinically resembling to an erysipelas.
 
Keywords: 
Skin; Toxicity; Chemotherapy; Pseudoscleroderma; Anthracycline
 
Full text article in PDF: 
Share this